Aromatase inhibitors for breast cancer

References

Citations

1. Smith IE, Chua S (2006). ABC of breast diseases. Medical treatment of early breast cancer. I: Adjuvant treatment. BMJ, 332(7532): 34–37.

2. ATAC Trialists' Group (2005). Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet, 365(9453): 60–62.

3. Abramowicz M (2005). Drugs for breast cancer. Treatment Guidelines From the Medical Letter, 3(29): 1–6.

4. Goss PE, et al. (2003). A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. New England Journal of Medicine, 349(19): 1793–1802.

5. Attar E, Bulun S (2006). Aromatase inhibitors: The next generation of therapeutics for endometriosis? Fertility and Sterility, 85(5): 1307–1318.

Author:	Kathe Gallagher, MSW Ralph Poore	Last Updated: October 19, 2007
Medical Review:	Joy Melnikow, MD, MPH - Family Medicine Donald Sproule, MD, CM, CCFP, FCFP - Family Medicine Douglas A. Stewart, MD - Medical Oncology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.